Tenet Healthcare Corporation
THC Healthcare Medical Care Facilities
Tenet Healthcare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $21.3 billion, up 3.07% from fiscal 2024.
- Revenue
- +6.47%
- EPS
- +291.1%
- Free cash flow
- +39.2%
- Total debt
- +0.42%
Quarter to September 2026, against a year earlier
Follow THC
Alert me
Tenet Healthcare Corporation (THC) EV/EBITDA
As of 5 November 2026, Tenet Healthcare Corporation (THC) trades at a EV/EBITDA of 4.7×. Over the past ten years it has ranged from 3.1× (December 2024) to 10.9× (July 2015); the current reading is higher than 10% of that period. That is below the Medical Care Facilities industry median of 11.9× and below the Healthcare sector median of 8.4×.
EV/EBITDA, daily
Embed this chart
Annual newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 6.4× | 94.96% |
| FY2024 | 3.3× | (47.76%) |
| FY2023 | 6.3× | 3.86% |
| FY2022 | 6.1× | 3.63% |
| FY2021 | 5.9× | (3.32%) |
| FY2020 | 6.1× | (20.37%) |
| FY2019 | 7.6× | 16.87% |
| FY2018 | 6.5× | (17.22%) |
| FY2017 | 7.9× | 4.60% |
| FY2016 | 7.5× | (16.12%) |
Quarterly newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| Sep 2026 | 4.3× | 2.28% |
| Jun 2026 | 4.3× | (17.23%) |
| Mar 2026 | 5.1× | (19.96%) |
| Dec 2025 | 6.4× | (1.13%) |
| 43 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| THC Tenet Healthcare Corporation | 4.7× |
| FMS Fresenius Medical Care AG & Co. KGaA compare | 5.1× |
| UHS Universal Health Services, Inc. compare | 6.4× |
| DVA DaVita Inc. compare | 8.0× |
| EHC Encompass Health Corporation compare | 10.7× |
| CON Concentra Group Holdings Parent, Inc. compare | 14.0× |
| PACS PACS Group, Inc. compare | 16.2× |
| CHE Chemed Corporation compare | 16.3× |
| ENSG The Ensign Group, Inc. compare | 16.4× |
| Medical Care Facilities industry median | 11.9× |
| Healthcare sector median | 8.4× |
| Market median | 10.9× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on THC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement